Vincerx Pharma Inc (VINC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VINC Annual Balance Sheets →
This page allows investors to track Vincerx Pharma Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent4.44
Marketable Securities, Current SH0.00
Cash & Short-term Investments4.00
Grants Receivable, Current0.00
Other Current Assets0.13
Prepaid Expense, Current AS0.12
Total Current Assets4.69
Equipment/Property/Plant Net0.00
Grants Receivable, Noncurrent0.00
Other Assets, Noncurrent0.00
Restricted Cash Current0.08
Operating Lease Right Of Use Asset-
Total Assets4.69
Liabilities
Accounts Payable, Current AC2.27
Accrued Liabilities, Current AC0.35
Other Liabilities, Current0.00
Total Current Liabilities2.62
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Common Stock Warrant Liabilities Current-
Total Liabilities2.62
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock196.08
Retained Earnings / Accumulated Deficit-194.19
Other Equity0.17
Common Stockholder's Equity2.07
Total Stockholder's Equity2.07
Liabilities & Stockholder's Equity4.69
4 historic quarters locked

Sign in to unlock the full Vincerx Pharma Inc balance sheet history.

About Vincerx Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250331)
  • Filed with the SEC: May 15, 2025
  • Source: d903288d10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-120762

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.